← Back to SBC Medical Group Holdings Inc
Stoqly stoqly.net Company report · October 27, 2026

SBC Medical Group Holdings Inc

SBC Nasdaq· Services-Offices & Clinics Of Doctors Of Medicine

Last close · Oct 27, 2026

$5.21

KIRA · Stoqly’s AI analyst, in plain words

  • SBC Medical Group Holdings Inc had $174M of revenue in fiscal 2025, down 15.5% on the year before.
  • Its operating margin was 38.9%, up 4.6 pts: of every 100 in sales, about 39 is left after running the business.
  • SBC Medical Group Holdings Inc made $51.0M of net profit in fiscal 2025. From fiscal 2023 to 2025, diluted EPS grew 9.1% a year.
  • Free cash flow was $23.3M in fiscal 2025, 13.4% of revenue.
  • SBC Medical Group Holdings Inc returned $5.0M to shareholders in fiscal 2025, 21% of free cash flow. The diluted share count rose 6.7%.
  • SBC Medical Group Holdings Inc has $121M more cash than debt.

Market cap

$534M

P/E

10.9x

Revenue

$174M

Net income

$51.0M

Free cash flow

$23.3M

Operating margin

38.9%

SBC Medical Group Holdings Inc in 30 seconds · fiscal 2025

Weak

Are sales growing?

−15.5%

No. Sales fell 15.5% last year.

Good

Does it make a profit?

29.4%

Yes. It keeps 29.4% of every sale as profit.

Good

Does profit turn into cash?

13.4%

Yes. 13.4% of sales ends up as free cash.

Good

Is debt under control?

Net cash

Yes. It has more cash than debt.

Weak

How healthy are the accounts?

3 / 9

Weak. It passes 3 of 9 health tests.

For information

How is the share priced?

10.9x

One share costs 10.9 times its yearly profit per share.

What SBC Medical Group Holdings Inc does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K · Mar 27, 2026
Legal name
SBC Medical Group Holdings Inc
CIK
0001930313
stoqly.net · SBC · Generated October 27, 2026 Not investment advice · Page 1 of 3
Stoqly stoqly.net Company report · October 27, 2026

SBC Medical Group Holdings Inc · SBC

Results and finances

The last 3 fiscal years. Amounts in USD.

Fiscal yearFY23FY24FY25
Sales and profit
Revenue $194M $205M $174M
Revenue growth — 6.1% −15.5%
Gross margin 70.9% 76.0% 73.3%
Operating margin 36.5% 34.2% 38.9%
Net income $39.4M $46.6M $51.0M
Net margin 20.3% 22.7% 29.4%
Diluted EPS $0.42 $0.48 $0.50
Cash
Cash from operations $50.7M $20.6M $24.7M
Capital expenditure $8.5M $2.6M $1.4M
Free cash flow $42.1M $18.0M $23.3M
FCF margin 21.8% 8.8% 13.4%
Share buybacks — $0.0M $5.0M
Share count change — 2.5% 6.7%
Debt and strength
Cash and short-term investments $103M $125M $164M
Debt incl. finance leases $1.0M $6.9M $43.3M
Shareholders' equity $142M $195M $248M
Net debt / EBITDA −1.2x −1.6x −1.7x
Current ratio 1.8x 3.0x 3.8x
Interest coverage 1,559.8x 2,484.2x 455.4x
Returns and quality
Return on capital 114.4% 59.4% 34.5%
Return on equity 27.7% 27.6% 23.0%
Return on tangible equity 33.1% 24.7% 27.5%
Piotroski F-score — 6 3
Altman Z'' 6.8 10.0 8.4

Insiders bought, 12 months

$0.0M

0 insiders

Insiders sold, 12 months

$20.1M

1 insider

Of sales under plans

0%

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net · SBC · Generated October 27, 2026 Not investment advice · Page 2 of 3
Stoqly stoqly.net Company report · October 27, 2026

SBC Medical Group Holdings Inc · SBC

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $5.21 a share, the company is worth $534M: 10.9 times its earnings of the last four quarters.

Source: SEC EDGAR XBRL filings (CIK 0001930313). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.